METHODS FOR IN VIVO EXPANSION OF CD8+ T CELLS AND PREVENTION OR TREATMENT OF GVHD

PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION

TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR

MCL1 INHIBITORS

Polymorphic Compounds And Uses Thereof

COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME

NOVEL PHARMACEUTICAL SALTS AND POLYMORPHIC FORMS OF AN ERBB AND BTK INHIBITOR

PYRAZINE AMIDE DERIVATIVES

TEAD Targeting Compounds and Methods Thereof

METHOD OF TREATING OCULAR DISORDERS WITH COMPOUNDS FOUND IN HARDERIAN GLAND SECRETIONS

MICRO- AND NANO-FLUIDIC CHIP, METHOD OF FABRICATING THE SAME, AND APPLICATIONS THEREOF

MICRO- AND NANO-FLUIDIC CHIP, METHOD OF FABRICATING THE SAME, AND APPLICATIONS THEREOF

D GLUTAMATE POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS

RAS INHIBITORS

THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER

Compositions For and Methods of Preventing Metastases

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR TREATMENT OF GRAFT VERSUS HOST DISEASE

ANALYTICAL METHOD AND THERAPEUTICAL AGENT FOR USE IN COMBINATION WITH L-ASPARAGINASE IN TUMOUR THERAPY

METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY

USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK

USE OF ANNEXINS IN PREVENTING AND TREATING CARDIAC NEURONAL CELL MEMBRANE INJURY AND DISEASE

Therapeutic Compositions for the Treatment of Dry Eye Disease

COMPOSITION FOR PREVENTING OR TREATING DENTAL CARIES

Compositions and Methods for Treating Neuropathy

Pharmaceutical Composition for Postpartum Recovery and Treatment of Pelvic Floor Dysfunction

COMPOSITIONS AND METHODS OF TREATMENT FOR CONGENITAL DIARRHEAL DISORDER

BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION

DOSE REGIMEN OF VICASINABIN

METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS

ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OF SYSTEMIC DISEASES IN CATS

COMBINATION THERAPY USING A PTPN11 INHIBITOR AND AN EGFR INHIBITOR

METHODS OF TREATING CHOLANGIOCARCINOMA

USE OF DEXTROMETHORPHAN IN COMBINATION WITH CYP2D6 AND CYP3A4 ENZYME INHIBITORS FOR THE TREATMENT OF PAIN

USE OF IPTACOPAN FOR THE TREATMENT OF LUPUS NEPHRITIS

MEDICINE CONTAINING VITAMIN D DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, USED IN COMBINATION WITH IMMUNOMODULATORY SUBSTANCE

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

Piezo Inhibition for Wound Healing

ASYMMETRIC ALLYL TRYPTAMINES

FORMULATIONS COMPRISING TRIPTAN COMPOUNDS

METHODS AND COMPOSITIONS FOR TREATING COLORECTAL CANCER WITH INDOXYL SULFATE

COMPOUNDS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS

METHOD FOR TREATING LOCAL LESION DISEASE

METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES

PROTEIN BIOMARKERS OF INFLAMMATORY ACTIVITY IN MULTIPLE SCLEROSIS

CANCER STEM CELL MARKER AND CANCER STEM CELL TARGETING DRUG

METHODS OF TREATING OSMIDROSIS

COMBINATION THERAPY INCLUDING ANTIBODIES THAT BIND EGFR AND CMET

TREATMENT OF ALVEOLAR SOFT PART SARCOMA (ASPS) WITH ATEZOLIZUMAB

METHODS OF TREATING AL AMYLOIDOSIS

Treatment of Parkinson's Disease

VEGF-C MUTEINS FOR SELECTIVE LYMPHATIC STIMULATION

URSOLIC ACID MORPHOLINE SALT

PYRIDONE COMPOUND HAVING INTEGRASE INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF

System and Method for Inventory Planning in a Supply Chain Network

ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS

N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES

Biphenyl and Phenylpyridine Compounds

CATIONIC LIPID COMPOUNDS FOR USE IN LIPID NANOPARTICLES

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES

IL-18 POLYPEPTIDES MODIFIED WITH POLYMERS

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

RAS INHIBITORS

CD19 CAR NK CELLS FOR USE IN METHODS OF TREATING CANCER

METHODS FOR DETECTING AND REVERSING IMMUNE THERAPY RESISTANCE

CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS

Compositions and Methods for Diagnosing and Treating Intellectual Disabilities

TREATMENT OF WOMEN AFFECTED WITH POLYCYSTIC OVARY SYNDROME

LISINOPRIL FORMULATIONS

BOYSENBERRY, APPLE, AND BLACKCURRANT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

ABIRATERONE DECANOATE PRODRUGS AND USE IN THERAPY

COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER

TREATMENT COMPOSITION FOR TREATING CHRONIC PAIN AND MIXED PAIN SITES

TREATMENT OF CLEAR CELL RENAL CELL CARCINOMA

METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY ASSOCIATED WITH AUTISM SPECTRUM DISORDER, RETT SYNDROME, AND FRAGILE X SYNDROME

METHODS AND COMPOSITIONS FOR TREATING VASOMOTOR SYMPTOMS

METHODS OF TREATING CANCER AND OTHER CONDITIONS WITH A MU OPIOID RECEPTOR ANTAGONIST

METHODS OF TREATING MIGRAINE

METHODS OF TREATING MIGRAINE

Methods of Treating Disorders Associated with Overactivation of IKKB

DUAL INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 AND TDO) AND THEIR USE IN THERAPY

CONTINUOUS DOSING REGIMEN FOR TREATMENT OF A CONDITION OF THE EYE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLIOBLASTOMA WITH A DUAL TARGETING ANTI-TUMOR COMPOSITION

USE OF AMISULPRIDE AS AN ANTI-EMETIC

Method of Preventing and Treating Chemotherapy- Induced Alopecia

TREATMENT OF STK11-LOSS CANCERS

TREATMENT FOR HOT FLUSHES

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

PHARMACOLOGICAL PROPHYLACTICS AGAINST STRESS-INDUCED AFFECTIVE DISORDERS IN FEMALES

COMBINATION OF ANTISPASMODIC AND ANESTHETIC AGENTS FOR TOPICAL PRODUCTS AND THEIR METHOD OF USE

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT

SUPRAMOLECULAR IONIZABLE LIPID MOLECULES WITH HETEROATOMIC TUNING FOR NUCLEIC ACID DELIVERY

Compositions and Methods for Application Over Skin

THERAPEUTIC AND DIAGNOSTIC METHODS FOR BLADDER CANCER

MICROBIAL SIGNATURES OF AUTISM SPECTRUM DISORDER

RECOMBINANT POXVIRUSES FOR CANCER IMMUNOTHERAPY

TARGETING NEUROPILIN 2 (NRP2) IN LETHAL PROSTATE CANCER

SOLUBILIZED APYRASES, METHODS AND USE

PLASMIN-BINDING VHHS

COMBINING CD27 AGONISTS AND IMMUNE CHECKPOINT INHIBITION FOR IMMUNE STIMULATION

ANTI GLUCOCORTICOID-INDUCED TNFR-RELATED (GITR) PROTEIN ANTIBODIES AND USES THEREOF

ANTI-FLT3 ANTIBODIES AND COMPOSITIONS

ANTI-TREM1 ANTIBODIES AND RELATED METHODS

ANTI-TIGIT ANTIBODIES AND USES OF THE SAME

COMBINATION THERAPY FOR COLORECTAL CARCINOMA

USE OF ANTI-CLAUDIN-1 ANTIBODIES TO INCREASE T CELL AVAILABILITY

IL-6 INHIBITOR AS TREATMENT FOR NEPHROPATHY

USE OF TGF-ALPHA POLYPEPTIDE OR ANTI-TGF-ALPHA ANTIBODIES FOR THE TREATMENT OF DISEASES AND DISORDERS

USE OF FCRN ANTAGONISTS FOR TREATMENT OF GENERALIZED MYASTHENIA GRAVIS

CYCLOSPORINE COMPOSITIONS AND METHODS OF USE

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES

BRIDGED RING COMPOUNDS AND THEIR THERAPEUTIC USE AS CNS AGENTS

BENZOQUINOLONE INHIBITORS OF VMAT2

5-[7-(3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBONYL)-1,2,3,4 TETRAHYDROISOQUINOLIN-6-YL]-1H-PYRROLE-3-CARBOXAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS

METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA

MORPHOLINE-3-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES

HETEROCYCLIC INHIBITORS OF GLUT9 FOR TREATMENT OF DISEASE

CRYSTALLINE FREEBASE FORMS OF A BIPHENYL COMPOUND

METHODS TO TREAT GENE MUTATION AND MUSCULAR DEGENERATIVE DISEASE

Systems and Methods for Treating Blood

METHODS AND MATERIALS FOR INHIBITING/PREVENTING THE TRAFFICKING OF MONOCYTES TO THE CENTRAL NERVOUS SYSTEM

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

TEMPERATURE-SENSITIVE HYDROGEL FOR CANCER TREATMENT CAPABLE OF PHOTOTHERMAL THERAPY AND PREPARATION METHOD THEREFOR

ACOUSTIC ENRICHMENT OF ADOPTIVE CELL TRANSFERS

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

TOPICAL THERAPEUTIC FORMULATIONS

THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN

Formulated and/or Co-Formulated Liposome Compositions Containing Toll-Like Receptor (TLR) Agonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof

G ALPHA Q/11 INHIBITORS FOR USE AS AN ANALGESIC

PROTEIN INTERFACES

PHOTORESPONSIVE PEPTIDE DELIVERY SYSTEM AND METHOD OF USING THE SAME

CO-ADMINISTRATION OF A CO-CRYSTAL OF PSILOCYBIN AND PSILOCIN WITH AN ATYPICAL ANTIPSYCHOTIC

NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS

TREATMENT FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION WITH GUANETHIDINE AND GUANADREL

TREATMENT FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION WITH GUANETHIDINE AND GUANADREL

METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS

METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

COMBINATION THERAPY OF SOLID CANCER

CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION

OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE

COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER

TREATMENTS AND PREVENTION OF OPIOID NEONATAL ABSTINENCE SYNDROME

BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE, MYODEGENERATIVE, AND LYSOSOMAL STORAGE DISORDERS

METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE

COMBINATION OF SMALL MOLECULE CD-47 INHIBITORS WITH OTHER ANTI-CANCER AGENTS

COMBINATION TREATMENT FOR CANCER

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION

Methods for Fructokinase Meditation of Alcohol Craving and Alcohol Induced Liver Disease

DISULFONATE STILBENES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES

METHOD OF TREATMENT AND SELECTION OF PATIENTS BENEFITING FROM AGOMELATINE BASED ON EEG MEASUREMENTS

USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF GASTROINTESTINAL DISEASES AND INFLAMMATION

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

Oral Powder Mixture With Small Sized Particles

TARGETED LIPOSOMAL GEMCITABINE AND METHODS THEREOF

SINGLE SOLUTION HYDROGELS WITH COVALENT BONDING FORMED IN SITU, COMPOSITION DESIGN AND MEDICAL PROCEDURES USING THE HYDROGELS

PRE-DOSING METHOD OF ASSESSING DRUG BENEFITS IN PATIENTS

ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)

METHOD OF TREATING CANCER USING WRS INHIBITORS

METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS

DUPILUMAB FOR TREATMENT OF COVID-19

SPECIFIC DOSAGE REGIMEN FOR HEMIBODY THERAPY

Combination of Broadly Neutralizing HIV Antibodies and Viral Inducers

CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS

FGF21 VARIANTS

ANTIVIRAL PEPTIDES AND METHODS OF USE THEREOF

CPG AMPHIPHILES AND USES THEREOF

PSYCHEDELIC COMPOUNDS AND THEIR THERAPEUTIC USES

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF

INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES

COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS

A1H-BENZO[C][1,2]THIADIAZINE-2,2-DIOXIDES BEARING HETEROCYCLIC LINKERS AS SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS

NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF

TRYPTAMINE DERIVATIVES

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF

LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF

BIOMIMETIC VESICLES AND USES THEREOF

IL2 IMMUNOCONJUQATE PREPARATION

SUPER-OXIDE DISMUTASE SOLUBLE FIBER COMPOSITIONS AND METHODS OF USE

METHODS FOR SCAR REDUCTION BY CONVERTING SCAR FIBROBLASTS INTO ADIPOCYTES WITH HAIR FOLLICLE-DERIVED SIGNALS

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONS

Composition with Mitochondria-Activating Ingredient NRF, which has Telomere-Extending, Anti-Aging and Cell-Rejuvenating Function, and Method for Anti-Aging

ENGINEERED IMMUNOMODULATORY ACCESSORY CELLS IMPROVE ALLOGENEIC ISLET TRANSPLANTATION WITHOUT IMMUNOSUPPRESSION

METHODS OF TREATING LEUKEMIA

COMPOSITIONS COMPRISING STING AGONISTS AND METHODS OF USE FOR TREATING GLIOMA

TOLL-LIKE RECEPTOR LIGANDS

NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS

NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS

NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS

METHODS OF TREATING OCULAR FIBROTIC PATHOLOGIES

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING CARNITINE ACYLCARNITINE CARRIER INHIBITOR AND PEROXISOMAL BETA OXIDATION INHIBITOR

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS

4-(6-OXO-2-(TRIFLUOROMETHYL)-3,6-DIHYDROCHROMENO[7,8-D]IMIDAZOL-8-YL)BENZONITRILE FOR USE IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH MOVEMENT DISORDERS

MOLECULAR JACKHAMMER FOR MECHANICAL DESTRUCTION OF CELLULAR STRUCTURE

ANTIMICROBIAL AMINO ESTERS

TOPICAL FORMULATION TO DECREASE SKIN INFLAMMATION OR REDNESS

HPDL INHIBITORS AND USES THEREOF

NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

HYDROGEL INCLUSION COMPLEX INCLUDING PHYSIOLOGICALLY ACTIVE MATERIAL BOUND TO THERMOSENSITIVE POLY(PHOSPHAZENE) BY HOST-GUEST INTERACTION USING BETA-CYCLODEXTRIN AND USE THEREOF

IL10 RECEPTOR BINDING MOLECULES AND METHODS OF USE

COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A PD-1 PATHWAY INHIBITOR, AND AN IMMUNOTHERAPEUTIC AGENT

RECOMBINANT ANTIBODY, KIT COMPRISING THE SAME, AND USES THEREOF IN DIAGNOSING CANCERS

BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss

HETEROCYCLIC DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

PROTACs of MALT1

INHIBITORS OF MENIN-MLL INTERACTION

PYRIMIDO AROMATIC RING COMPOUND AND USE THEREOF IN DRUG

COMPOUNDS AND METHODS OF USE

CDK9 INHIBITOR AND USE THEREOF

MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER

HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF CANCER

Deuterium-Enriched Nirmatrelvir as SARS-CoV-2 Mpro Inhibitor for the Treatment of COVID-19

Compounds and Their Use for Treatment of Hemoglobinopathies

CHEMICAL TARGETING SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4 (SMARCA4) AND USE IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

DUAL LSD1/HDAC INHIBITORS

ARTICLE FOR USE WITH AN APPARATUS FOR HEATING AN AEROSOL GENERATING AGENT

LINKER PAYLOADS AND CONJUGATES THEREOF

ANTIBODY-DRUG CONJUGATES TARGETING EGFR/C-MET AND PREPARATION METHODS AND USES THEREOF

ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF

MITOCHONDRIAL INTERVENTION IN NEUROLOGICAL DISORDERS

HIGHLY ACTIVE NK CELL AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF PSORIASIS

MATERIALS AND METHODS FOR THE PREVENTION OF RHEUMATOID ARTHRITIS

METHODS AND COMPOSITIONS FOR THE CONTROL OF INFLAMMATION IN SKIN DISEASE

PEPTIDES AND METHODS OF USE THEREOF IN TREATING OCULAR DISORDERS

THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

COMPOSITION AND METHOD FOR IMPROVING LIPID METABOLISM FUNCTION OF SUBJECT

UROLITHIN COMBINATION

PURIFIED ANTHELMINTIC COMPOSITIONS AND RELATED METHODS

Cell Therapy

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

METHODS OF TREATING CHRONIC KIDNEY DISEASE WITH DAPAGLIFLOZIN

Method Of Treating, Reducing, Or Alleviating A Medical Condition In A Patient

METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS

METHODS OF TREATING EPILEPSY OR STATUS EPILEPTICUS

USE OF HPK1 INHIBITOR IN TREATMENT OF INTERFERON-RELATED DISEASES

COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE

USE OF DEXTROMETHORPHAN IN COMBINATION WITH CYP2D6 AND CYP3A4 ENZYME INHIBITORS FOR THE TREATMENT OF PAIN

SMALL MOLECULES FOR INHIBITING CHEMOKINE ACTIVITY AND/OR CANCER CELLS GROWTH

COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER

COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING ANTICANCER AGENT AND NOVEL COMPOUND HAVING INHIBITORY ACTIVITY WITH RESPECT TO PROSTAGLANDIN E2 RECEPTORS

(AMPAR-PAM)-NMDA RECEPTOR ANTAGONIST COMBINATION THERAPY FOR TREATMENT OF MENTAL CONDITIONS AND DISORDERS

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

Treating Chronic Myelomonocytic Leukemia with CXCL8 Receptor Inhibitors

METHODS OF USE OF BENZALDEHYDE COMPOSITIONS

POULTICE AND METHOD FOR MANUFACTURING SAME

PHARMACEUTICAL FORMULATION

LYMPHATIC DELIVERY OF NANOPARTICLES TO TREAT NEURODEGENERATIVE, NEUROLOGICAL, AND EYE CONDITIONS

CATIONIC LIPID ANALOGUES, COMPOSITIONS AND USES THEREOF

OIL-IN-WATER EMULSION WITH AGAR AND DIACETYL TARTARIC ACID ESTERS OF MONO-AND DI-GLYCERIDES (DATEM)

MODIFIED MONOCYTES/MACROPHAGES/DENDRITIC CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND USES IN DISEASES AND DISORDERS ASSOCIATED WITH PROTEIN AGGREGATES

METHODS FOR TREATING PROSTATE AND LUNG CANCER

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER-FAMILY RECEPTORS

COMPOSITIONS INCLUDING CYTOTOXIC INNATE LYMPHOID CELLS AND USES THEREOF

METHODS OF TREATING BLOOD DISORDERS WITH VWF-TARGETED MONOSPECIFIC ANTIBODIES

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT

ACTIVIN SIGNALING ACTIVITY

ANTI-IL-27 ANTIBODIES AND USES THEREOF

COMBINATION TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN PATIENTS WITH RAS PATHWAY MUTATIONS

ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CONONAVIRUS SARS-COV-2

PEPTIDE ANALOGS

METHOD FOR REALIZING CONTROLLED RELEASE AND SUSTAINED RELEASE OF ACTIVITY OF BIOACTIVE MOLECULES AND USE FOR DRUGS

PEPTIDES FOR TREATING PAIN OR REDUCING PAIN SENSITIVITY

TREPROSTINIL PRODRUGS

RAS INHIBITORS

FUSED PYRIMIDINES AS KRAS INHIBITORS

PROTEIN DEGRADERS DEVELOPED ON BASIS OF BCL-2 FAMILY PROTEIN LIGAND COMPOUNDS AND USE THEREOF

OXER1 ANTAGONISTS AND USES THEREOF

BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS

Crystalline pharmaceutically acceptable salt and polymorphic form of the glutaminyl cyclase inhibitor Varoglutamstat

MCL-1 INHIBITORS

POLYCYCLIC COMPOUND AND USE THEREOF

SMALL MOLECULES FOR TREATING CANCER, INHIBITING CHEMOKINE ACTIVITY AND/OR INDUCING CELL DEATH

SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING BREAST CANCER

LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF

ANTI-TROP2 ANTIBODY COMBINATION THERAPIES AND METHODS OF USE THEREOF

COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY

CD70 COMBINATION THERAPY

COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS

IMMUNOGENIC COMPOSITION FOR PARATUBERCULOSIS

Mutant Peptides And Methods Of Treating Subjects Using The Same

FORMULATIONS AND METHODS FOR SKIN CARE

COMBINATIONS OF CHECKPOINT INHIBITORS AND ONCOLYTIC VIRUS FOR TREATING CANCER